Datar Cancer Genetics joins hands with U.S. based Iylon Precision Oncology to offer personalized Precision Oncology cancer treatment solutions
Share Article
Datar Cancer Genetics has announced its partnership with U.S. based Iylon Precision Oncology to offer Iylon’s innovative personalized Precision Oncology cancer treatment recommendations. Datar Cancer Genetics has been at the forefront in developing greater insight into the cancer ecosystem and offering its molecular and cell analysis based innovative product services to clinicians and patients globally.
Datar Cancer Genetics
“Iylon is proud to partner with Datar Cancer Genetics to offer their patients state of the art recommendations with the latest in cancer care,” said Prof. Sendurai Mani, co-founder of Iylon Precision Oncology.